Insider · CIK 0001500322

Goldsmith Bruce A

Reports to the SEC for 2 companies · WESTMINSTER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001500322

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-05-27	PASGPassage BIO, Inc. · Stock Option (Right to Buy)A Award	Director, CEO and President	AAward	+100K sh	—	—	100,000
2022-03-21	PASGPassage BIO, Inc.P Purchase	Director, CEO and President	PPurchase	+10K sh	$3.15	+$31.5K	15,983
2022-02-10	PASGPassage BIO, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+400K sh	—	—	400,000
2021-05-21	PASGPassage BIO, Inc.P Purchase	Director, CEO and President	PPurchase	+2,000 sh	$13.12	+$26.2K	5,983
2021-02-16	PASGPassage BIO, Inc. · Stock Option (right to buy)A Award	Director, CEO and President	AAward	+262K sh	—	—	262,000
2020-03-03	PASGPassage BIO, Inc.P Purchase	Director, CEO and President	PPurchase	+1,100 sh	$18.00	+$19.8K	1,100
2012-09-04	ALLOS THERAPEUTICS INCU Disposition from Tender	SVP, Corporate Development	UDisposition from Tender	−347K sh	$1.82	−$631K	0
2012-03-01	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−4,473 sh	$1.50	−$6,690.266	346,933
2012-02-29	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−4,505 sh	$1.52	−$6,869.224	351,406
2012-02-28	ALLOS THERAPEUTICS INCA Award	SVP, Corporate Development	AAward	+180K sh	—	—	355,911
2012-02-24	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−575 sh	$1.54	−$888.088	176,184
2012-02-23	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−2,500 sh	$1.58	−$3,958	176,759
2011-11-16	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−300 sh	$1.43	−$429.51	179,259
2011-11-15	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−12.5K sh	$1.44	−$18K	179,559
2011-02-28	ALLOS THERAPEUTICS INCA Award	SVP, Corporate Development	AAward	+67.3K sh	—	—	192,024
2011-02-24	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−507 sh	$3.12	−$1,582.601	124,726
2011-02-23	ALLOS THERAPEUTICS INCS Sale	SVP, Corporate Development	SSale	−2,250 sh	$3.25	−$7,312.5	125,233
2010-10-20	ALLOS THERAPEUTICS INCA Award	SVP, Corporate Development	AAward	+101K sh	—	—	127,483

Recent filings

Accepted (ET)
Jun 14
Goldsmith Bruce A0001209191-22-033158
SEC(opens sec.gov)
Mar 234
Goldsmith Bruce A0001209191-22-020791
SEC(opens sec.gov)
Feb 144
Goldsmith Bruce A0001787297-22-000002
SEC(opens sec.gov)
May 214
Goldsmith Bruce A0001209191-21-035051
SEC(opens sec.gov)
Feb 184
Goldsmith Bruce A0001209191-21-012156
SEC(opens sec.gov)
Mar 34
Goldsmith Bruce A0001209191-20-015623
SEC(opens sec.gov)
Sep 54
Goldsmith Bruce A0001127602-12-025792
SEC(opens sec.gov)
Mar 14
Goldsmith Bruce A0001127602-12-009005
SEC(opens sec.gov)
Feb 274
Goldsmith Bruce A0001127602-12-008159
SEC(opens sec.gov)
Nov 174
Goldsmith Bruce A0001127602-11-029987
SEC(opens sec.gov)
Mar 24
Goldsmith Bruce A0001127602-11-008484
SEC(opens sec.gov)
Feb 254
Goldsmith Bruce A0001127602-11-007732
SEC(opens sec.gov)
Oct 224
Goldsmith Bruce A0001127602-10-025901
SEC(opens sec.gov)

Companies

Address

11080 CIRCLEPOINT ROAD SUITE 200

WESTMINSTER, CO, 80020